Skip to main content
OpenTrials

Clinical trial condition

Stage IV Lung Cancer AJCC v8

Explore clinical trials studying Stage IV Lung Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

123 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Lung Cancer AJCC v8 trial results

Active, Not Recruiting

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

NCT05633602

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 566 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

NCT03965689

Conditions
Lung Diseases, Lung Neoplasms, Metastatic Lung Non-Small Cell Squamous Carcinoma, +12 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View Trial Details
Active, Not Recruiting

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

NCT05215769

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • St. Rita's Lima, Ohio, United States
  • Saint Francis Medical Center Richmond, Ohio, United States
  • Saint Elizabeth Youngstown Hospital Youngstown, Ohio, United States
View Trial Details
Active, Not Recruiting

Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study

NCT03410043

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • University of Colorado Denver, Colorado, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

NCT03391869

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +15 more
Locations
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson West Houston Houston, Texas, United States
  • MD Anderson League City League City, Texas, United States
View Trial Details
Active, Not Recruiting

Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)

NCT04268550

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
View all 306 locations
View Trial Details

Related conditions